Home > Insider Trading > Filing (0001179110-15-006433)

Filing Details

Accession Number:: 0001179110-15-006433
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-04-17 18:56:49
Reporting Period:: 2015-04-15

Filing Date:: 2015-04-17
Accepted Time:: 2015-04-17 18:56:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1578850	Gregory Neil Almstead	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Evp Research Pharma Ops & Tech	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-04-15	5,400	$68.35	4,111	No	4	S	Direct
Common Stock	Disposition	2015-04-15	4,111	$69.04	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,295	Indirect	By spouse

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$51.00	2025-01-01	69,550	69,550	Direct
Common Stock	Stock Option (Right to Buy)	$27.05	2024-01-27	40,000	40,000	Direct
Common Stock	Stock Option (Right to Buy)	$10.85	2023-05-15	70,312	70,312	Direct
Common Stock	Stock Option (Right to Buy)	$10.85	2023-05-15	9,688	9,688	Direct
Common Stock	Stock Option (Right to Buy)	$218.40	2022-01-10	166	166	Direct
Common Stock	Stock Option (Right to Buy)	$490.80	2021-04-27	216	216	Direct
Common Stock	Stock Option (Right to Buy)	$1,149.60	2020-02-02	200	200	Direct
Common Stock	Stock Option (Right to Buy)	$451.20	2019-05-15	200	200	Direct
Common Stock	Stock Option (Right to Buy)	$735.60	2018-04-01	194	194	Direct
Common Stock	Stock Option (Right to Buy)	$735.60	2018-01-25	166	166	Direct
Common Stock	Stock Option (Right to Buy)	$626.40	2017-04-18	137	137	Direct
Common Stock	Stock Option (Right to Buy)	$392.40	2016-03-01	119	119	Direct
Common Stock	Stock Option (Right to Buy)	$226.80	2015-05-24	106	106	Direct
Common Stock	Stock Option (Right to Buy)	$51.00	2025-01-01	2,060	2,060	Indirect
Common Stock	Stock Option (Right to Buy)	$27.05	2024-01-27	1,300	1,300	Indirect
Common Stock	Stock Option (Right to Buy)	$10.85	2023-05-15	600	600	Indirect
Common Stock	Stock Option (Right to Buy)	$218.40	2022-01-10	7	7	Indirect
Common Stock	Stock Option (Right to Buy)	$490.80	2021-04-27	7	7	Indirect
Common Stock	Stock Option (Right to Buy)	$1,149.60	2020-02-02	1	1	Indirect
Common Stock	Stock Option (Right to Buy)	$508.80	2019-10-07	12	12	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-01-01	69,550	69,550	Direct
2024-01-27	40,000	40,000	Direct
2023-05-15	70,312	70,312	Direct
2023-05-15	9,688	9,688	Direct
2022-01-10	166	166	Direct
2021-04-27	216	216	Direct
2020-02-02	200	200	Direct
2019-05-15	200	200	Direct
2018-04-01	194	194	Direct
2018-01-25	166	166	Direct
2017-04-18	137	137	Direct
2016-03-01	119	119	Direct
2015-05-24	106	106	Direct
2025-01-01	2,060	2,060	Indirect
2024-01-27	1,300	1,300	Indirect
2023-05-15	600	600	Indirect
2022-01-10	7	7	Indirect
2021-04-27	7	7	Indirect
2020-02-02	1	1	Indirect
2019-10-07	12	12	Indirect

Footnotes

The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.74 to $68.60 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.79 to $69.65 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014.
This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting quarterly thereafter beginning on April 1, 2013.
Currently exercisable.
This option was granted on May 15, 2013 and vests over two years, with 50% of the shares underlying the option vested on May 15, 2014 and the remaining 50% of the original number of shares underlying the option vesting on May 15, 2015.